These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8719483)

  • 1. Cellular and humoral immunity to vascular endothelium and the development of cardiac allograft vasculopathy.
    Hosenpud JD; Everett JP; Morris TE; Wagner CR; Shipley GD
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S185-7. PubMed ID: 8719483
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of histoincompatibility in cardiac allograft vasculopathy.
    Costanzo MR
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S180-4. PubMed ID: 8719482
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of endothelial antigens associated with transplant-associated coronary artery disease.
    Wheeler CH; Collins A; Dunn MJ; Crisp SJ; Yacoub MH; Rose ML
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S188-97. PubMed ID: 8719484
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of antibody and indirect antigen presentation in transplant-associated coronary artery vasculopathy.
    Rose ML
    J Heart Lung Transplant; 1996 Apr; 15(4):342-9. PubMed ID: 8732592
    [No Abstract]   [Full Text] [Related]  

  • 5. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
    Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
    Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular rejection of human cardiac allografts and the role of humoral immunity in chronic allograft rejection.
    Hammond EH; Ensley RD; Yowell RL; Craven CM; Bristow MR; Renlund DG; O'Connell JB
    Transplant Proc; 1991 Apr; 23(2 Suppl 2):26-30. PubMed ID: 2063418
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiendothelial antibodies after heart transplantation: the accelerating factor in transplant-associated coronary artery disease?
    Crisp SJ; Dunn MJ; Rose ML; Barbir M; Yacoub MH
    J Heart Lung Transplant; 1994; 13(1 Pt 1):81-91; discussion 91-2. PubMed ID: 7909446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunology insights into cardiac allograft rejection.
    Savasta M; Lentini S
    Rev Cardiovasc Med; 2011; 12(2):e68-76. PubMed ID: 21796085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
    Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
    Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Initial experiences in diagnosis of graft rejection following clinical heart transplantation. Detection of graft-directed activated T-cells].
    Werner M; Otto U; Keitel R; Klötzer B; Schürer KD; Walther J; Vogt S; Ambrosius H
    Zentralbl Chir; 1990; 115(14):905-12. PubMed ID: 2238967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy.
    Bayliss J; Bailey M; Leet A; Stein AN; Thomson NM; McLean CA
    Transplantation; 2008 Oct; 86(7):991-7. PubMed ID: 18852667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac allograft vasculopathy: do adipocytes bridge alloimmune and metabolic risk factors?
    Wehner JR; Baldwin WM
    Curr Opin Organ Transplant; 2010 Oct; 15(5):639-44. PubMed ID: 20689436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal reduction in acute rejection after heart transplantation is not associated with a reduction in cell-mediated responses to donor-specific vascular endothelium.
    Hosenpud JD; Shipley GD; Mauck KA; Morris TE; Wagner CR
    J Heart Lung Transplant; 1995; 14(5):926-37. PubMed ID: 8800729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift.
    Mehra MR; Ventura HO; Stapleton DD; Smart FW
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S207-11. PubMed ID: 8719487
    [No Abstract]   [Full Text] [Related]  

  • 15. Accelerated arteriosclerosis in heart transplant recipients: an immunopathology study of 22 transplanted hearts.
    Hruban RH; Beschorner WE; Baumgartner WA; Augustine SM; Reitz BA; Hutchins GM
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1230-2. PubMed ID: 1989197
    [No Abstract]   [Full Text] [Related]  

  • 16. The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation.
    Fredrich R; Toyoda M; Czer LS; Galfayan K; Galera O; Trento A; Freimark D; Young S; Jordan SC
    Transplantation; 1999 Feb; 67(3):385-91. PubMed ID: 10030283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelitis in cardiac allograft biopsy specimens: possible relationship to antibody-mediated rejection.
    Tavora F; Munivenkatappa R; Papadimitriou J; Drachenberg C; Sailey C; Mehra M; Burke A
    J Heart Lung Transplant; 2011 Apr; 30(4):435-44. PubMed ID: 21193326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of combined heart and kidney transplantation: a French multicenter study.
    Vermes E; Grimbert P; Sebbag L; Barrou B; Pouteil-Noble C; Pavie A; Obadia JF; Loisance D; Lang P; Kirsch M
    J Heart Lung Transplant; 2009 May; 28(5):440-5. PubMed ID: 19416771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium.
    Hosenpud JD; Everett JP; Morris TE; Mauck KA; Shipley GD; Wagner CR
    Circulation; 1995 Jul; 92(2):205-11. PubMed ID: 7600652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophages and transplant arteriosclerosis: known and novel molecules.
    Russell ME
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S111-5. PubMed ID: 8719472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.